Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

- PMLiVE

Life Healthcare Comms expands creative team

Chris Owens, Catriona Hampton and Kerry Stevenson join

Biogen promotes Dr Paul McKenzie

He becomes pharmaceutical operations and technology EVP

Bristol-Myers Squibb (BMS) building

BMS to explore new options for its immuno-oncology drug Opdivo

Partners with PsiOxis to research its use with enadenotucirev

- PMLiVE

Merck & Co signs cancer vaccines research deal for Keytruda

Will work on range of personalised vaccines to complement its blockbuster

- PMLiVE

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA

mylife YpsoPump given green light for use with pump cartridge NovoRapid PumpCart

- PMLiVE

Boehringer Ingelheim launches AI-powered animal health website

The new site uses ‘machine learning’ to tailor content to users’ requirements

- PMLiVE

Dr Keith Bragman joins Alacrita

He becomes a partner at the firm’s London office

- PMLiVE

Tracking comms trends: communication and market access

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

Syneos Health®

Envigo appoints Dr Adrian Hardy as president and CEO

He succeeds Brian Cass in the role

- PMLiVE

Tracking comms trends: communication and market access

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

- PMLiVE

Connected Healthcare

Digital technologies are bringing healthcare professionals (HCPs) and their patients ever closer, and the potential benefits of this type of engagement seem to be many.

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links